Literature DB >> 10910539

Thrombocytosis in children at one medical center of southern Taiwan.

H L Chen1, S S Chiou, J M Sheen, R C Jang, C C Lu, T T Chang.   

Abstract

Thrombocytosis in children is common, but usually without symptoms. The causes of thrombocytosis in children are considered to be mostly due to infection, trauma, surgery, blood disease, prematurity, renal disease and chronic inflammation. To evaluate the incidence and etiology of thrombocytosis of the hospitalized patients, patients who were admitted to the Pediatric Department of Kaohsiung Medical College Hospital (KMCH) from October 1996 to November 1997 were studied. There were 2910 cases studied and 220 cases (127 male and 93 female) had thrombocytosis (> or = 500 x 10(9)/L) with a rate of 7.6%. The causes of thrombocytosis are infections (49.5%), Kawasaki disease (6.4%), postsplenectomy (7.8%), blood diseases (3.7%), malignancies (3.2%), renal disorders (3.2%), prematurity (3.2%), tissue damage (4.5%), chronic inflammation (1.8%), recovery from marrow suppression (1.3%), immunologic disturbances (2.2%), essential thrombocythemia (0.5%), and miscellaneous factors (3.7%). Thrombocytosis associated with multiple, simultaneous causative factors was found in 9.0% of these cases. Thrombocytosis secondary to infectious diseases or Kawasaki disease was significantly more common in children under 2 years old. The most commonly associated infectious disease was respiratory tract infection (61.1%). There were 29 children (13.2%) presenting a platelet count of more than 800,000/mm3. However, no thrombotic complications were seen in any of the children. By far, the major cause of thrombocytosis in our cases was reactive in character. Most of the thrombocytosis cases were due to infections, inflammatory diseases, or Kawasaki disease.

Entities:  

Mesh:

Year:  1999        PMID: 10910539

Source DB:  PubMed          Journal:  Acta Paediatr Taiwan        ISSN: 1608-8115


  2 in total

1.  Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea.

Authors:  Vikas Dua; Satya Prakash Yadav; Vijay Kumar; Renu Saxena; Anupam Sachdeva
Journal:  Int J Hematol       Date:  2012-10-07       Impact factor: 2.490

2.  Extreme thrombocytosis in admissions to paediatric intensive care: no requirement for treatment.

Authors:  Alison Denton; Peter Davis
Journal:  Arch Dis Child       Date:  2007-06       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.